Bioident wins illustrious 2007 Wall Street Journal Technology Innovation Awards

Printed semiconductor-based technology named co-winner for Lab-on-a-Chip with real-time results

04-Oct-2007

Bioident Technologies Inc. announced that the company is a co-winner in the semiconductor category for the seventh annual Wall Street Journal contest for Technology Innovation. Bioident was awarded for the development of its PhotonicLab Platform(TM), which enables rapid in-vitro diagnostics, chemical and biological threat detection, and environmental testing without the need for off-site lab analysis.

Utilizing the latest breakthroughs in science and nanotechnology, the Bioident PhotonicLab Platform is used to produce the world's first disposable photonic lab-on-achip solution for next-generation mobile analytics applications, such as water and food analysis, chemical and biological agent detection, and point-of-care diagnostics. employs a process developed by its parent company, Austria's Nanoident Technologies AG, for using an inkjet printer to print electronic circuits on a variety of surfaces, such as plastic foil or glass; the technology makes it possible to apply photosensitive semiconductors directly onto a lab-on-a-chip. The Platform eliminates the need for complex and expensive readout systems and delivers unprecedented mobility and sensitivity based on existing biological and chemical assays.

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 whitepaper
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 whitepaper